These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15372412)

  • 21. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy.
    Erbs S; Gielen S; Linke A; Möbius-Winkler S; Adams V; Baither Y; Schuler G; Hambrecht R
    Am Heart J; 2003 Aug; 146(2):280-5. PubMed ID: 12891196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease.
    Jambrik Z; Venneri L; Varga A; Rigo F; Borges A; Picano E
    Am Heart J; 2004 Oct; 148(4):684-9. PubMed ID: 15459601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of endothelial dysfunction in Asian Indian patients with chronic kidney disease and changes following renal transplantation.
    Sharma J; Kapoor A; Muthu R; Prasad N; Sinha A; Khanna R; Kumar S; Garg N; Tewari S; Sharma RK; Goel P
    Clin Transplant; 2014 Aug; 28(8):889-96. PubMed ID: 24930933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
    Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
    Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and comparison of endothelial function between dialysis and kidney transplant patients.
    Kocak H; Ceken K; Dinckan A; Mahsereci E; Yavuz A; Yucetin L; Akbas SH; Gurkan A; Erdogan O; Ersoy F; Yakupoglu G; Demirbas A; Tuncer M
    Transplant Proc; 2006 Mar; 38(2):416-8. PubMed ID: 16549135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
    Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
    J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes of endothelium-dependent and endothelium-independent dilatation of brachial arteries in patients with coronary heart disease].
    Li XP; Zhang XY; Zhao SP
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):276-8. PubMed ID: 12212166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.
    Taal MW; Sigrist MK; Fakis A; Fluck RJ; McIntyre CW
    Nephron Clin Pract; 2007; 107(4):c177-81. PubMed ID: 17975325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure.
    Heitzer T; Baldus S; von Kodolitsch Y; Rudolph V; Meinertz T
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1174-9. PubMed ID: 15831810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of serum cystatin C with C-reactive protein and apolipoprotein A1 in patients on hemodialysis.
    Samouilidou EC; Grapsa E
    Ren Fail; 2008; 30(7):711-5. PubMed ID: 18704820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between biomarkers of carbonyl stress with increased systemic inflammatory response in different stages of chronic kidney disease and after renal transplantation.
    Aveles PR; Criminácio CR; Gonçalves S; Bignelli AT; Claro LM; Siqueira SS; Nakao LS; Pecoits-Filho R
    Nephron Clin Pract; 2010; 116(4):c294-9. PubMed ID: 20639676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
    Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
    J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B; Anderstam B; Suliman M; Alvestrand A
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.